Stefan Klostermann
19Patents
4h-index
56Co-inventors
59Inventor score
Filing activity: Oct 18, 2010 → Nov 4, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9914776B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 10 | Active |
| US10253104B2 | Bispecific antibodies against CD3ϵ and BCMA | Chemistry; Metallurgy | 6 | Active |
| US10611840B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 4 | Active |
| US10611841B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 4 | Active |
| US9150641B2 | Sequence dependent aggregation | Chemistry; Metallurgy | 3 | Active |
| US11117965B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 2 | Active |
| US9766251B2 | Anti-human IgG1 antibody | Chemistry; Metallurgy | 1 | Active |
| US12157770B2 | Anti-HLA-G antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US10418126B2 | Method for improving antibody stability | Physics | 0 | Active |
| US12098213B2 | Antibodies binding to HLA-A2/WT1 | Chemistry; Metallurgy | 0 | Active |
| US10766967B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 0 | Active |
| US9957331B2 | Non-cross-reactive anti IgG antibodies | Physics | 0 | Active |
| US11952421B2 | Bispecific antibodies against CD3EPSILON and ROR1 | Chemistry; Metallurgy | 0 | Active |
| US11987632B2 | Antibodies binding to HLA-A2/MAGE-A4 | Chemistry; Metallurgy | 0 | Active |
| US12378315B2 | Anti-rabbit CD19 antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US10047162B2 | Sequence dependent aggregation | Chemistry; Metallurgy | 0 | Active |
| US11680110B2 | Three-dimensional structure-based humanization method | Chemistry; Metallurgy | 0 | Active |
| US11981737B2 | Anti-HLA-G antibodies and use thereof | Physics | 0 | Active |
| US11192957B2 | Antibodies binding to HLA-A2/WT1 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.